Articles from: EuroIntervention
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
In this new Journal column, the authors take different sides to debate the future of transcatheter mitral valve replacement and whether it will remain a niche therapy or evolve into another breakthrough technology in interventional cardiology. https://t.co/EPJkPSCrsb https://t.co/EPJkPSCrsb - view on twitter
Mashup Score:4
EuroInterventionDiagnostic accuracy of optical flow ratio: an individual patient-data meta-analysis - 1 day
Mashup Score:4
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
OFR enables functional and morphological assessment of coronary artery stenoses including an evaluation of stent expansion and apposition with the use of a single catheter. @EuroInterventio @escardio @AbbottCardio @mirvatalasnag @jedicath @nickaram https://t.co/DZV2RsXIYj https://t.co/DZV2RsXIYj - view on twitter
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
In this study on DES, endothelial coverage starts within days, BP-DES may heal faster than DP-DES with smooth muscle cell infiltration. Limited strut coverage at 30 days in both, healing substantial at 90 days. Read more. https://t.co/YaPjHVepzp https://t.co/YaPjHVepzp - view on twitter
Mashup Score:20
EuroInterventionEffects of PCSK9 inhibitors on platelet function - 2 days
Mashup Score:20
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
"Effects of PCSK9 inhibitors on platelet function". Read or listen to the audio augmented version of the Editorial by @RaberLorenz and Yasushi Ueki. #EAPCI https://t.co/fqsX7aeg3x https://t.co/fqsX7aeg3x - view on twitter
More coverage:
#eapci
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
This randomized, pharmacodynamic study in patients with ASCVD on clopidogrel treatment and with LDL-C levels ≥70 mg/dL showed that, compared to placebo, evolocumab in adjunct to statin therapy did not significantly reduce platelet reactivity at 30 days. https://t.co/c699gH3PSO https://t.co/c699gH3PSO - view on twitter
Mashup Score:36
EuroInterventionTranscatheter mitral valve replacement will remain a niche therapy: pros and cons - 4 days
Mashup Score:36
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
EIJ DEBATE 🔥 "Transcatheter mitral valve replacement will remain a niche therapy: pros and cons" by David J. Cohen, @SebLudwig1, @nicolo_piazza, @djc795 #EAPCI https://t.co/8Unehqjqu6 https://t.co/8Unehqjqu6 - view on twitter
More coverage:
#eapci
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
🆕 The TAVI-SMALL 2 registry showed that in small aortic annuli, implantation of supra-annular and self-expanding valve was associated with a more favourable forward haemodynamic profile than after intra-annular and balloon-expandable valve implantation. https://t.co/21plfiT93e https://t.co/21plfiT93e - view on twitter
Mashup Score:29
EuroInterventionClopidogrel: still king of the ring for elective percutaneous coronary intervention! - 5 days
Mashup Score:29
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
"Clopidogrel is the P2Y12 inhibitor of choice for elective percutaneous coronary intervention and is recommended in the current guidelines for the management of chronic coronary syndrome". Read the Editorial by G. Montalescot and @arnaud_ferrante. #EAPCI https://t.co/7gAM5BKf4Q https://t.co/7gAM5BKf4Q - view on twitter
More coverage:
#eapci
Mashup Score:30
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
In this study of patients undergoing PCI for chronic coronary syndromes, prasugrel/ticagrelor showed similar safety and efficacy to clopidogrel at 1 year with no significant difference in death, MI, bleeding, stroke and target vessel revascularization. https://t.co/m4TY1Dep6s https://t.co/m4TY1Dep6s - view on twitter
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
In patients with complex CAD, non-fatal periprocedural major adverse events were more common following CABG than PCI, but their prognostic impact was similar, being significant in the first year and then diminishing out to 10 years. Read more. https://t.co/XquTl5AVx1 https://t.co/XquTl5AVx1 - view on twitter